Patients #1, #4, #5, #7 and #9 presented with a breast cancer with homogeneous presence of a PIK3CA mutation in each individual tumour component, whereas PIK3CA mutations were heterogeneously distributed in the tumours of patients #3 and #6 (Table 2). Here, PIK3CA is linked to breast cancer.